* Globeimmune announces delisting and deregistration of
common stock from nasdaq capital market
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
The post BRIEF-Globeimmune to delist and deregister common stock from Nasdaq Capital Market appeared first on NASDAQ.